StreetInsider.com News Articles

TempraMed Signs Letter of Intent with CPO Greece for Exclusive Distribution of VIVI Products in Greece

Tue, 01 Sep 2026 06:45:00 -0400

Distribution framework pairs TempraMed's injectable medication-protection products with one of the largest, most established Greek pharmacy and healthcare distributors

Highlights:

LOI with CPO Greece includes exclusive distribution of VIVI Cap™ and VIVI Epi™ throughout Greece, subject to a definitive agreement.
Proposed exclusivity is conditional on minimum annual purchase obligations, with combined purchases required to increase by at least 20% year over year to maintain exclusivity.
Transfer pricing and the first-year minimum unit commitment will be negotiated and established in the definitive distribution agreement.
CPO Greece brings an established pharmacy division, local distribution infrastructure and experience representing international healthcare and consumer brands.
Adding and renewing

TempraMed Signs Letter of Intent with CPO Greece for Exclusive Distribution of VIVI Products in Greece

Tue, 01 Sep 2026 06:45:00 -0400

Distribution framework pairs TempraMed's injectable medication-protection products with one of the largest, most established Greek pharmacy and healthcare distributors
Highlights:
LOI with CPO Greece includes exclusive distribution of VIVI Cap™ and VIVI Epi™ throughout Greece, subject to a definitive agreement.
Proposed exclusivity is conditional on minimum annual purchase obligations, with combined purchases required to increase by at least 20% year over year to maintain exclusivity.
Transfer pricing and the first-year minimum unit commitment will be negotiated and established in the definitive distribution agreement.
CPO Greece brings an established pharmacy division, local distribution infrastructure and experience representing international healthcare and consumer brands.
Adding and renewing

TempraMed Signs Letter of Intent with CPO Greece for Exclusive Distribution of VIVI Products in Greece

Tue, 01 Sep 2026 06:45:00 -0400

Distribution framework pairs TempraMed's injectable medication-protection products with one of the largest, most established Greek pharmacy and healthcare distributors
Highlights:
LOI with CPO Greece includes exclusive distribution of VIVI Cap™ and VIVI Epi™ throughout Greece, subject to a definitive agreement.
Proposed exclusivity is conditional on minimum annual purchase obligations, with combined purchases required to increase by at least 20% year over year to maintain exclusivity.
Transfer pricing and the first-year minimum unit commitment will be negotiated and established in the definitive distribution agreement.
CPO Greece brings an established pharmacy division, local distribution infrastructure and experience representing international healthcare and consumer brands.
Adding and renewing

TempraMed Signs Letter of Intent with CPO Greece for Exclusive Distribution of VIVI Products in Greece

Tue, 01 Sep 2026 06:45:00 -0400

Distribution framework pairs TempraMed's injectable medication-protection products with one of the largest, most established Greek pharmacy and healthcare distributors
Highlights:
LOI with CPO Greece includes exclusive distribution of VIVI Cap™ and VIVI Epi™ throughout Greece, subject to a definitive agreement.
Proposed exclusivity is conditional on minimum annual purchase obligations, with combined purchases required to increase by at least 20% year over year to maintain exclusivity.
Transfer pricing and the first-year minimum unit commitment will be negotiated and established in the definitive distribution agreement.
CPO Greece brings an established pharmacy division, local distribution infrastructure and experience representing international healthcare and consumer brands.
Adding and renewing